Adenosine for the Management of Neonatal and Pediatric Supraventricular Tachycardia

Contributing Editor: Marcia L. Buck, Pharm.D.; Editorial Board: Kristi N. Hofer, Pharm.D.; Michelle W. McCarthy, Pharm.D.

Disclosures

Pediatr Pharm. 2008;14(8) 

In This Article

Formulary Update

The following actions were taken by the Pharmacy and Therapeutics Committee at their meeting on 7/25/08:

1. Nitazoxanide (Alinia® ) was added for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum or treatment of Clostridium difficile colitis.

2. Conivaptan (Vaprisol® ), a vasopressin V1A and V2 antagonist, was added for the treatment of euvolemic and hypervolemic hyponatremia.

3. The restrictions on the use of argatroban and fondaparinux (Arixtra®) were removed.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....